Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PBMs Were On Capitol Hill, But Pharma Still Took Some Heat

Executive Summary

Drug makers remained front and center during the Senate Finance Committee's third hearing on drug pricing, even though leaders from five pharmacy benefit managers were testifying.

Advertisement

Related Content

Insulin Assistance Programs: Big Help Or Just A Band-Aid?
Rebate Reshuffle: Could Pharma Foot The Bill To Offset Higher Premiums?
Express Scripts Insulin Program Lowers Cost Sharing With Supplemental Manufacturer Discounts
No More Rebates: HHS Proposed Rule Revises Anti-Kickback Safe Harbor

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC125041

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel